Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00483054
What this trial is testing

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 142
Post-approval studies (Phase 4)Study completedNCT02775929
What this trial is testing

Partners Demonstration Project of PrEP and ART

Who this might be right for
HIV Infection
University of Washington 1,013
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Large-scale testing (Phase 3)Study completedNCT00324103
What this trial is testing

Structured Treatment Interruptions in Chronic HIV Infection

Who this might be right for
HIV Infection
Istituto Superiore di Sanità 600
Not applicableStudy completedNCT01232361
What this trial is testing

IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Who this might be right for
ADHDHIV
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 127
Not applicableEnrolling By InvitationNCT06488846
What this trial is testing

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Who this might be right for
HIV Infections
University of California, San Francisco 1,000
Not applicableStudy completedNCT00007488
What this trial is testing

HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 164
Not applicableStudy completedNCT02043769
What this trial is testing

Pediatric Enhanced Surveillance Study

Who this might be right for
Human Immunodeficiency Virus (HIV)Acquired Immune Deficiency Syndrome (AIDS)
Columbia University 396
Large-scale testing (Phase 3)Study completedNCT00043966
What this trial is testing

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Who this might be right for
HIV Infections
Abbott 200
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT02174159
What this trial is testing

Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Ended earlyNCT00120783
What this trial is testing

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 40
Not applicableStudy completedNCT01310023
What this trial is testing

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

Who this might be right for
Antiretroviral Toxicity
Harvard School of Public Health (HSPH) 5,169
Not applicableActive Not RecruitingNCT04593680
What this trial is testing

Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

Who this might be right for
Drug Interaction
Thai Red Cross AIDS Research Centre 20
Not applicableUnknownNCT05848427
What this trial is testing

The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

Who this might be right for
COVID-19
Lebanese University 1,000
Large-scale testing (Phase 3)Study completedNCT01095796
What this trial is testing

Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 707
Very early researchStudy completedNCT04820933
What this trial is testing

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

Who this might be right for
HIV I InfectionCardiovascular Risk FactorLipid Metabolism Disorders
University of Texas Southwestern Medical Center 26
Not applicableStudy completedNCT02301533
What this trial is testing

Provider and Peer Support Intervention to Improve ART Adherence Among Kenyan Men Who Have Sex With Men

Who this might be right for
Medication Adherence
University of Washington 60
Not applicableStudy completedNCT01140633
What this trial is testing

Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda

Who this might be right for
HIV-infection/Aids
Massachusetts General Hospital 46
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Next Page